Zydus Secures USFDA Final Approval For Ivabradine Tablets

The United States Food and Drug Administration (USFDA) has granted final clearance to Zydus Lifesciences for Ivabradine tablets, 5 mg and 7.5 mg (USRLD: Corlanor Tablets, 5 mg and 7.5 mg). Ivabradine is indicated to reduce the risk of...

Ascendis Pharma Signs Pact with Teijin To Develop TransCon hGH

Ascendis Pharma A/S announced an exclusive licensing agreement with Teijin Limited for the further development and marketing of TransCon hGH, TransCon PTH, and TransCon CNP for endocrinology rare illness in Japan. “We are pleased to partner with...

Boehringer Ingelheim and IBM Partner To Advance Generative AI

Boehringer Ingelheim and IBM established a collaboration in which Boehringer would leverage IBM's foundation model technology to uncover unique candidate antibodies for the development of effective medicines. “We are very excited to collaborate...

MedTech Innovations and Digital Breakthroughs: Announcing the 2023 Pharma IT Summit

A notable pharmaceutical company in India faced significant challenges in overseeing its complex IT infrastructure. Obsolete legacy systems, inconsistent data sources, and the need to comply with strict regulatory requirements hampered innovation.

SpringWorks's Ogsiveo Bags USFDA Nods to Treat Desmoid Tumours

SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced that Ogsiveo (nirogacestat), an oral gamma secretase inhibitor, has been approved by the US Food and Drug...

HempStreet Secures $1M in Pre-Series-A for Global Expansion

India's HempStreet and the first Ayurvedic cannabis research retail company have raised $1 million in a pre-A round. The round was led by their current investor,

FDA Accepts Orexo's NDA for Opioid Overdose Rescue Medication

Swedish pharmaceutical company Orexo AB (publ.) announces that the US Food and Drug Administration (FDA) have approved

India Pharma Sector To Touch $130 Billion By 2030 Says Experts

As per industry analysts, India's pharmaceutical business might surpass USD 130 billion by 2030, owing to rising market potential and increased demand in international markets. They stated that the company's revenue for the fiscal year 2022-23 was...

Neumora Initiates Phase 1 Study to Treat Schizophrenia

Neumora Therapeutics, Inc. (Neumora), a clinical-stage biopharmaceutical company reinventing brain medication research, announced the start of a phase 1 single ascending dose/multiple ascending dosage trial in healthy adult volunteers to evaluate...

Indore's First IRCAD Surgical Training Center with SAIMS Collaboration

IRCAD India, a mirror institute of IRCAD France (Strasbourg), has recently been established in collaboration with the Sri Aurobindo Institute of Medical Sciences (SAIMS), Indore, India

© 2024 India Pharma Outlook. All Rights Reserved.